Expert Opinion on Therapeutic Targets
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.1 | Q1 | 82.0% | 1.383 | Q1 | 90.7% |
| 2024 | 4.4 | Q1 | 81.3% | 1.255 | Q1 | 89.3% |
| 2023 | 4.6 | Q1 | 84.5% | 1.423 | Q1 | 92.0% |
| 2022 | 5.8 | Q1 | 88.3% | 1.581 | Q1 | 93.6% |
| 2021 | 6.8 | Q1 | 89.9% | 1.444 | Q1 | 92.7% |
| 2020 | — | — | 1.964 | Q1 | 95.5% | |
| 2019 | — | — | 1.699 | Q1 | 94.1% | |
| 2018 | — | — | 1.470 | Q1 | 91.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-7631
ISSN
1472-8222
country
GBcoverage
1997-2026